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Abstract
Background: Leishmaniasis is a neglected tropical disease that is caused by an obligate intracellular protozoan of the
genus Leishmania. Recently, an increasing number of autochthonous leishmaniasis cases caused by L. martiniquensis
and the novel species L. siamensis have been described in Thailand, rendering an accurate diagnosis of this disease
critical. However, only a few laboratories are capable of diagnosing leishmaniasis in Thailand. To expand leishmaniasis
diagnostic capabilities, we developed a simple colorimetric loop-mediated isothermal amplification (LAMP) technique
for the direct detection of Leishmania DNA.
Methods: LAMP was performed for 75 min using four primers targeting the conserved region of the18S ribosomal
RNA gene, and the DNA indicator used was malachite green (MG). To simulate crude samples, cultured promastigotes
of L. siamensis were mixed with blood or saliva. Also, clinical samples (blood, saliva, and tissue biopsies) were obtained
from patients with cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL). All samples were boiled for 10 min and
introduced directly into the LAMP reaction mixture without DNA purification.
Results: The use of MG resulted in an unambiguous differentiation of positive and negative controls. For L. siamensis,
the detection limit was 103 parasites/mL or 2.5 parasites/tube. Saliva, tissue biopsies, and whole blood were indicative
of active Leishmania infection, and their direct usages did not adversely affect the detection limit. In addition, this
LAMP assay could detect DNA from multiple Leishmania species other than L. siamensis and L. martiniquensis, including
L. aethiopica, L. braziliensis, L. donovani and L. tropica.
Conclusions: The simplicity and sensitivity of LAMP in detecting active Leishmania infection could enable the rapid
diagnosis of leishmaniasis, thereby facilitating the survey and control of leishmaniasis in Thailand. However, our limited
number of samples warranted a further validation with a larger cohort of patients before this assay could be deployed.
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Background
Causing more than 50,000 deaths annually [1], leishman-
iasis is one of the most debilitating poverty-related dis-
eases and presents a severe threat to socioeconomic
development. This disease is caused by more than 20
species of the obligate intracellular protozoa Leishmania
[2]. These are transmitted to humans through the bites
of female sand flies [1]. Upon infection, three main
clinical forms can be recognized: cutaneous leishmaniasis
(CL), mucocutaneous leishmaniasis (MCL), and visceral
leishmaniasis (VL). CL, the most common form, is charac-
terized by the presence of various ulcerative lesions, which
lead to disfiguring and/or disabling scars [3, 4]. Conse-
quently, patients with CL often live in obscurity [5],
thereby preventing expeditious treatment and increasing
the probability of transmission. MCL is described by a se-
vere destruction of mucosal regions (nose, mouth, and
throat) [4]. VL is an infection of the internal organs that is
characterized by prolonged fever, anemia, hepatospleno-
megaly, and weight loss. VL is fatal if left untreated [6].
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Since the first case report in 1996 [7], indigenous leish-
maniasis has been increasingly prevalent in Thailand, espe-
cially in HIV patients. Case reports include both VL [7–12]
and CL [10, 11, 13–15] and are concentrated in the
northern and southern part of Thailand. In contrast
to other regions in Asia, most cases in Thailand are
caused by either L. martiniquensis or L. siamensis [12, 16].
As early detection is one of the most important aspects of
disease containment, the need for a robust and rapid diag-
nostic method has never been higher. To summarize, cur-
rently available methods can be divided into three groups:
parasitological methods, serological methods, and molecu-
lar methods, each of which presents various advantages
and disadvantages.
Parasitological methods, which include microscopy and
parasite culturing, have been considered the gold standard
in diagnosing leishmaniasis. In Thailand, however, only a
handful of laboratories could culture parasites. Also, sero-
logical diagnostic methods with comparable sensitivity to
parasitological methods have been developed; however,
most of them (enzyme-linked immunosorbent assay
(ELISA) [17, 18], immunofluorescence antibody test (IFA)
[19], and western blotting [20]) require sophisticated instru-
ments, limiting their usages in healthcare environments.
Moreover, these serological techniques have never been
evaluated for the diagnosis of leishmaniasis in Thailand.
Molecular methods with great sensitivities and specific-
ities have also been developed to diagnose leishmaniasis.
One of the most classical techniques, polymerase chain
reaction (PCR), is widely used [21–24]. However, the re-
quirements for expensive equipment, DNA purification,
and gel visualization have forestalled its utilization in field
settings.
In 2000, Notomi et al. [25] developed the loop-
mediated isothermal amplification (LAMP) method. In
short, this method uses several complex primers and a
strand-displacement polymerase to achieve amplifica-
tion. Though conceptually challenging, LAMP has sev-
eral advantages over PCR from a field diagnostics point
of view. 1) The reaction proceeds isothermally, thereby
obviating the need for expensive thermal cyclers [25]. 2)
Crude DNA extracts can be used directly without purifi-
cation [25, 26]. 3) The products can be detected visually
using multiple parameters, including turbidity, fluores-
cence, and color.
Nevertheless, turbidity is challenging to discern and is
unstable over time. Fluorescence measurement requires
costly dyes (SYBR Green I [27], calcein [28], propidium
iodide [29]) and is technically inconvenient due to its re-
quirement for UV illumination. Due to their inhibitory
effects, these dyes must be introduced post-reaction, in-
creasing contamination risks. Colorimetric measure-
ments are among the most straightforward of all of the
detection methods. Several dyes have been reported to
be useful, such as hydroxynaphthol blue (HNB) [30] and
malachite green (MG) [31]. HNB requires the operator
to distinguish between blue and violet, which can be am-
biguous. In contrast, MG only requires distinction be-
tween blue and transparency.
LAMP has also been applied for the detection of L. infan-
tum, both in dogs and humans [32, 33]. Pan-leishmania
LAMP is also reported by Karani et al., Mikita et al. and
Nzelu et al. [26, 31, 34]. However, Leishmania–specific col-
orimetric LAMP from clinical samples has never been
described.Therefore, in this study, we developed a LAMP
method using MG to detect Leishmania DNA from crude
clinical samples. These data can be useful for the deploy-
ment of LAMP in field settings and can further enable de-




To develop a pan-leishmania assay, we chose the highly
conserved 18S ribosomal RNA gene, as in previous pan-
leishmania assays [26, 31, 34]. A consensus sequence
was made from nine different Leishmania species, in-
cluding L. tropica [GenBank: KF041809.1], L. martini-
quensis [KJ467218.1], L. mexicana [KF041806.1], L.
hertigi [KF041804.1], L. donovani [KF041801.1], L. cha-
gasi (syn. L. infantum) [KF041797.1], L. infantum
[KF302752.1], L. amazonensis [KF302746.1], and L.
enriettii [KF041798.1]. However, L. siamensis was not
included in this process due to the absence of its se-
quences on GenBank. The consensus sequence was
imported into the PrimerExplorer version 4 software
(http://primerexplorer.jp/elamp4.0.0/index.html), and
primers were designed to avoid any mutations that were pre-
sented. To ensure optimality, primers with the lowest change
in Gibb’s free energy (ΔG) for dimer formation and the high-
est change in hybridization ΔG were chosen. The primers’
thermodynamic properties were further validated using the
OligoCalc software (http://www.basic.northwestern.edu/
biotools/oligocalc.html). A final verification of specificity
was performed using Basic Local Alignment Search Tool
(BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis
against human DNA and any other organisms included in
the differential diagnosis of leishmaniasis. The resulting
primers are shown in Table 1 and Fig. 1, and were synthe-
sized by BioDesign Co., Ltd, Pathumthani, Thailand.
Quantitative polymerase chain reaction
The 25 μl reaction mixture contained 12.5 μl of 2× reaction
mix from the SuperScript® III Platinum® SYBR® Green One-
Step qRT-PCR Kit (Life Technologies, USA), 0.08 μM of F3
primer, 0.08 μM of B3 primers, and 1 U of BIOTAQ™ DNA
Polymerase (Bioline, Germany). The reaction was per-
formed using the CFX96™ real-time PCR system (Bio-Rad
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Laboratories, USA) and was programmed as followed:
3 min of initial denaturation at 95 °C, 40 cycles of denatur-
ation at 95 °C for 20 sec, annealing at 50 °C for 30 sec, ex-
tension at 72 °C for 40 sec, and fluorescence data
acquisition at 77 °C. Upon completion, a final extension at
72 °C for 10 min ensued. The Cq (quantification cycle) was
defined to be 10 times the standard deviation of the base-
line. A standard curve was generated using DNA dilutions
in triplicates, and the efficiency was determined to be
98.44 % with a linear range spanning 6 orders of magni-
tudes. Specificities of all samples were verified using melt-
ing curve analyses, which demonstrated a single peak at
83.5 °C.
Loop-mediated isothermal amplification
The LAMP reaction mixtures (25 μl) were based on
that described by Tomita et al. [28], which contained
1× Isothermal Amplification Buffer (New England
Biolabs, USA), 8 mM MgSO4, 0.8 M Betaine (Sigma-
Aldrich, USA), 1.4 mM each of dATP, dCTP, dGTP,
and dTTP (SibEnzyme, Russia), 40 pmol of FIP primer, 40
pmol of BIP primer, 10 pmol of F3 primer, 10 pmol of B3
primer, and 8 U of Bst 2.0 WarmStart® DNA Polymerase
(New England Biolabs, USA). In addition, the colorimetric
indicator, 0.008 % MG (Sigma-Aldrich, USA) was added.
The reaction was performed at 65 °C for 75 min using the
Veriti® 96-well Thermal Cycler (Life Technologies, USA).
Visualization of the LAMP products was performed using
2.5 % agarose gel electrophoresis at 10 V/cm in 1× TAE
buffer.
Promastigote culture
L. siamensis isolate PCM2 and L. martiniquensis isolate
CU1 were used in this study and were derived from
bone marrow aspirates of infected patients. The culture
media was Schneider’s insect medium (Sigma-Aldrich,
USA) supplemented with 10 % fetal bovine serum, 100
U of penicillin (Sigma-Aldrich, USA), and 100 μg/ml
streptomycin (Sigma-Aldrich, USA). The cultures were
incubated at 25 ± 2 °C, and subculturing was done every
2–3 days at a ratio of 1:2.
Reference DNA
All Leishmania DNA samples used in this study were ex-
tracted using the Invisorb® Spin Tissue Mini Kit (Stratec
Biomedical AG, Germany). While L. siamensis and L.
martiniquensis DNA were derived from cell culturing, L.
aethiopica, L. braziliensis, L. donovani, and L. tropica
DNA were derived from tissue biopsies of patients with
imported leishmaniasis. Trypanosoma brucei DNA was
extracted from a permanent slide sample, while Trichomo-
nas vaginalis and Giardia lamblia DNA were isolated
from infected patient samples at King Chulalongkorn
Memorial Hospital. All DNA samples were of suffi-
cient quality, as indicated by their optimal 260/280
and 260/230 ratios.
Detection limit
To generate standard parasite concentrations and assess
LAMP’s tolerance to inhibitors that can be presented in
the saliva, 10-fold dilutions of L. siamensis from 107–100
parasites/ml were made using either 1× phosphate-
buffered saline (PBS) or human saliva. Each dilution was
divided into two portions. One portion was extracted for
Fig. 1 Targeted Amplification Region on the 18S Ribosomal RNA Gene of L. martiniquensis (KJ467218.1)
Table 1 Primer sequences used in the study
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DNA using the Invisorb® Spin Tissue Mini Kit (Stratec
Biomedical AG, Germany), and the other was boiled at
100 °C for 10 min, as described previously [26].
To simulate infected blood, 100 μl dilutions of L. sia-
mensis in human blood were made as described above
and divided into two portions. The first portion was
added with Triton X-100 to a final concentration of 1 %,
and boiled at 100 °C for 10 min, which resulted in a co-
agulum. Next, 50 μl of ddH2O was added, and the co-
agulum was broken up by vigorous agitation with a
pipette tip. The second portion was subjected to DNA
extraction using the Invisorb® Spin Blood DNA Mini Kit
(Stratec Biomedical AG, Germany); 2.5 μl of each result-
ant was directly introduced to both qPCR and LAMP.
Clinical samples
Peripheral blood and saliva were obtained from two
patients.
Patient 1 was initially reported by Phumee et al. [35].
In short, the patient was a 49-year-old man who was
HIV positive and presented with multiple nodules on his
body. Microscopy and cell culturing revealed the pres-
ence of Leishmania parasites in the nodules, and mo-
lecular analysis confirmed L. martiniquensis infection
[16]. He was successfully treated with amphotericin B
and itraconazole. Blood, saliva, and tissue biopsy were
obtained. The blood was treated in the same manner as
described above, while the saliva and tissue biopsy
(drenched in 1× PBS) were boiled at 100 °C for 10 min.
2.5 μl of the supernatant were used as the template.
Patient 2 was described by Chusri et al. [10]. He was a
30-year-old man who was HIV positive. Similar to Pa-
tient 1, he had multiple papules on his skin, but this pa-
tient also had internal organ involvements. Leishmania
parasites were microscopically confirmed to be infiltrat-
ing the bone marrow and ulcers. Further molecular data
confirmed this Leishmania species to be L. martiniquen-
sis [16]. He was also successfully treated with amphoteri-
cin B and itraconazole. Blood, saliva, and bone marrow
biopsy were obtained. The saliva and blood was treated
as described earlier, and the bone marrow biopsy was
treated in the same manner as the blood.
Ethical statement
This study was approved by the Institutional Review
Board on Human Research of the Faculty of Medicine,
Chulalongkorn University (COA No. 725/2013).
Results
Both qPCR and LAMP successfully amplified regions
that were specified by the newly designed primers. For
LAMP, successful amplification was associated with
MG’s characteristic light blue color, whereas failed amp-
lification was associated with transparency (Fig. 2). Gel
electrophoresis of the LAMP products also exhibited
their characteristic “mixture of stem–loop DNAs with
various stem lengths, and cauliflower-like structures with
multiple loops” [25], which further confirmed their suc-
cessful amplifications.
The detection limits (log10 parasites/ml) of L. siamen-
sis for LAMP, as defined by the appearance of its light
blue color, and qPCR, as defined by fluorescence above
the Ct, are shown in Table 2.
For qPCR, our results indicated that the direct use of
the samples was possible but was associated with in-
creases in the detection limits. However, whole blood
could not be used, due to the total inhibition of Taq
polymerase.
Fig. 2 Detection of LAMP Products by MG-based Colorimetric Changes and Gel Electrophoresis. a LAMP was able to detect multiple species of
Leishmania. (aet = L. aethiopica; bra = L. braziliensis; don = L. donovani; tro = L. tropica; mar = L. martiniquensis; sia = L.siamensis) b LAMP could detect
L. siamensis in the presence of whole blood. Ten-fold dilutions of L. siamensis in whole blood (log parasites/ml) were lysed, boiled, and subjected
to LAMP. The black precipitates are coagulated blood
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In the case of LAMP, which is more tolerant of PCR
inhibitors, removal of the extraction process allowed a
lower detection limit of 103 parasites/ml across all sam-
ples. Crude samples did not affect the properties of MG
as all of the positive samples displayed MG’s characteris-
tic color. The use of whole blood did shift the color to-
ward a greenish tone, whereas the negative samples were
yellow in color (Fig. 2). However, an excessive amount of
whole blood or the presence of uncoagulated blood
could prevent the discrimination between positive and
negative results, as hemoglobin absorption spectrum
overlapped that of MG.
Clinical samples also yielded useful information in
microscopically diagnosed patients. Patient 1, who had
CL, had detectable Leishmania DNA in his saliva and
tissue biopsy. Patient 2, in contrast, who had CL and
VL, had the DNA presented in his bone marrow, blood,
and saliva (Fig. 3).
Discussion
With an increasing number of cases, leishmaniasis is
now an emerging infectious disease in Thailand. How-
ever, current diagnostic methods require experienced
personnel, advanced facilities, and a large amount of
time. Thus, simplification is now critical to bring diag-
nostics to point-of-care settings. Therefore, we devel-
oped the LAMP method to complement leishmaniasis
diagnostic process and to facilitate epidemiological stud-
ies of leishmaniasis in Thailand.
Molecular techniques have exploited multiple genes to
detect Leishmania, most of which are high-copy-number
genes, including cysteine protease B [36], gp63 [37], in-
ternal transcribed spacer 1 (ITS1) [38], 18S ribosomal
RNA [26, 31], and minicircle kinetoplast DNA [24]. As
expected, comparative studies have shown that the mini-
circles, which have the highest copy number, yield the
highest sensitivity [39, 40]. However, minicircles are
highly variable and due to LAMP’s requirement of six
conserved regions, it is not feasible to design pan-
leishmania LAMP primers that target minicircles. In our
approach, we chose the 18S ribosomal RNA gene, which
represents a balanced trade-off between copy number
and variability. As Karani et al., Mikita et al. and Nzelu
et al. recently reported, LAMP has been shown to detect
most species of Leishmania [26, 31, 34]. Here, we also
experimentally confirmed the detection of L. martini-
quensis and L. siamensis. Our detection limit was com-
parable to that of Mikita et al. (103 parasites/ml), but
was 10-fold higher than that of Nzelu et al. (102 para-
sites/ml) [26, 31].
We detected Leishmania DNA in the blood and bone
marrow, and in the tissue and saliva of the VL and CL
patient, respectively. Our findings agreed with others
that Leishmania DNA can be found in multiple noninva-
sive sources, including saliva (CL, VL) [10, 12, 41], skin
swabs (CL) [26] and peripheral blood (VL) [42, 43]. We
recommend the use of multiple DNA sources to reduce
the probability of false negatives.
Our results also suggested that LAMP could be used
to detect Leishmania DNA from crude clinical samples
without compromising the detection limit. Furthermore,
the use of crude samples even lowered the detection
limit by 10-fold (103 parasites/ml), but the same could
not be said with qPCR, which increased this limit by 10-
fold. We suspected that in the case of LAMP, the re-
moval of inhibitors did not compensate for the loss of
Table 2 Detection limits of LAMP and qPCR under various
conditions (log parasites/ml) (F* = Fail to amplify)
Diluent Method LAMP qPCR
1X PBS Boiled 3 5
Extracted 3 4
Saliva Boiled 3 4
Extracted 4 4
Whole blood Boiled 3 F*
Extracted 4 5
Fig. 3 LAMP Could Be Used Directly with Clinical Samples. Crude clinical samples were directly introduced into the LAMP reaction after being
subjected to heating. (NTC = no template control; N = healthy patient control; B = blood; S = saliva; T = tissue biopsy; BM = bone marrow)
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DNA from the extraction process, as in the case of
qPCR. These results are in concordance with other stud-
ies that used boiled samples in LAMP [26, 44, 45]. In
addition, of all of the DNA preparation methods com-
pared, Sun et al. [46] reported that simple boiling results
in the highest sensitivity.
Furthermore, the use of MG greatly facilitates the in-
terpretation of results as it is highly discernable and con-
sistent [31]. Because MG is inexpensive and can be
stored at room temperature, this dye could tremen-
dously increase the applicability of LAMP in the field.
Earlier attempts to couple direct blood samples with a
colorimetric detection method were unsuccessful, due to
the intense color of hemoglobin. To solve this problem,
we induced the precipitation of the blood using its own
coagulation system. We initially lysed the blood and its
accompanying parasites with Triton X-100 and then pro-
moted coagulation by boiling the sample. After boiling
the sample, the coagulum was pulverized using a pipette
tip. From this approach, we could clearly distinguish the
results using MG, even with 2.5 μl of whole blood.
Because LAMP can be performed isothermally using a
simple heat block, stable electricity is not required. Re-
cently, using phase-change material, LaBarre et al. [47]
developed a stable heat block that did not require elec-
tricity. Microfluidics lab-on-a-chip for LAMP has also
been developed and has enabled highly multiplexed re-
actions and further simplification [48]. Moreover, Tanner
et al. [49] reported that the LAMP reaction mixture can
be left at 37 °C for two hours without compromising the
detection limit. LAMP mixtures have also been lyophi-
lized with a reported storage time at room temperature
of at least seven months [50].
Nevertheless, because of the low prevalence of leish-
maniasis in Thailand, we could only obtain a small num-
ber of microscopically diagnosed patients. Future work
in a statistically significant group of patients is required
to warrant the performance of this method.
Also, LAMP is particularly prone to contamination due
to the large amount of DNA that it can generate, and its
capability to amplify minute amounts of DNA. During this
study, we nevertheless encountered multiple contamination
issues. Therefore, we recommend that post-amplification
reaction mixtures should not be opened due to aerosoliza-
tion risks, and that all proper precautions be taken [51]. To
prevent false positive results, no template control and
healthy patient control should also be used. We also
tested our assay specificity with T. vaginalis and G.
lamblia DNA, with satisfying results. However, our
assay did cross-react with DNA from Trypanosoma
sp., a closely related protozoon (data not shown).
Nevertheless, as each protozoon has a distinct set of
clinical presentations, this cross-reaction would not
impose a significant risk of misdiagnosis.
Conclusion
Sensitive molecular techniques to diagnose leishmaniasis
have been introduced; nevertheless, due to their com-
plexities, they have not yet been in widespread use.
However, as our results demonstrated, LAMP could be
used with unpurified clinical samples without comprom-
ising sensitivity and specificity, and its results could be
unambiguously interpreted using MG.
With the advent of LAMP, molecular techniques can
now be seamlessly integrated with field diagnostics. We
anticipate that this combination will be crucial for sur-
veying and controlling leishmaniasis in Thailand. How-
ever, further evaluation with a large cohort of patients
will be required before the assay can be confidently
deployed.
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